Post-earnings recap
Reported
Mon, Oct 28, 2013
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
Biogen's earnings report indicates a positive surprise in EPS, which contributed to a modest increase in stock price. The lack of revenue data and guidance may leave investors cautious. The stock's slight rise reflects investor confidence in the company's current performance despite uncertainties ahead.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.35 | N/A | +9.92% |
| Revenue | N/A | N/A | N/A |
Management expressed satisfaction with the earnings beat on EPS. They emphasized their commitment to pipeline development but did not provide specific guidance.
We are pleased with our EPS performance this quarter.
Our focus remains on advancing our pipeline.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—